BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liang C, Qi Z, Ge H, Liang C, Zhang Y, Wang Z, Li R, Guo J. Long non-coding RNA PCAT-1 in human cancers: A meta-analysis. Clinica Chimica Acta 2018;480:47-55. [DOI: 10.1016/j.cca.2018.01.043] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhu J, Guan J, Ji X, Song Y, Xu X, Wang Q, Zhang Q, Guo R, Wang R, Zhang R. A two-phase comprehensive NSCLC prognostic study identifies lncRNAs with significant main effect and interaction. Mol Genet Genomics 2022. [PMID: 35218396 DOI: 10.1007/s00438-022-01869-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Hua H, Wang J, Zhong P, Mou T, Liu P, Xie F. The clinical prognostic value of lncRNA LINC00675 in cancer patients: A meta-analysis. Medicine (Baltimore) 2021;100:e25244. [PMID: 33879657 DOI: 10.1097/MD.0000000000025244] [Reference Citation Analysis]
3 Zhang Y, Liang C, Zhang Y, Wang Z, Li R, Wei Z, Guo J. The role of FOXD2-AS1 in cancer: a comprehensive study based on data mining and published articles. Biosci Rep 2020;40:BSR20190372. [PMID: 33140822 DOI: 10.1042/BSR20190372] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Wang W, Zhao Z, Xu C, Li C, Ding C, Chen J, Chen T, Zhao J. LncRNA FAM83A-AS1 promotes lung adenocarcinoma progression by enhancing the pre-mRNA stability of FAM83A. Thorac Cancer 2021;12:1495-502. [PMID: 33687144 DOI: 10.1111/1759-7714.13928] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
5 Liang C, Yue C, Liang C, Ge H, Wei Z, Li G, Wu J, Huang H, Guo J. The Long Non-Coding RNA SBF2-AS1 Exerts Oncogenic Functions In Gastric Cancer By Targeting The miR-302b-3p/E2F Transcription Factor 3 Axis. Onco Targets Ther 2019;12:8879-93. [PMID: 31802900 DOI: 10.2147/OTT.S210697] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
6 Liang C, Zhang Y, Zhang Y, Li R, Wang Z, Wei Z, Guo J. The prognostic value of LINC01296 in pan-cancers and the molecular regulatory mechanism in hepatocellular carcinoma: a comprehensive study based on data mining, bioinformatics, and in vitro validation. Onco Targets Ther 2019;12:5861-85. [PMID: 31410029 DOI: 10.2147/OTT.S205853] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
7 Wang L, Xie Y, Fang H, Zhang X, Pan H, Yan S. Long noncoding RNA DANCR in various cancers: a meta-analysis and bioinformatics. Cancer Manag Res 2019;11:6581-92. [PMID: 31410056 DOI: 10.2147/CMAR.S200922] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
8 Yang ML, Huang Z, Wu LN, Wu R, Ding HX, Wang BG. lncRNA-PCAT1 rs2632159 polymorphism could be a biomarker for colorectal cancer susceptibility. Biosci Rep 2019;39:BSR20190708. [PMID: 31253700 DOI: 10.1042/BSR20190708] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
9 Cui YS, Song YP, Fang BJ. The role of long non-coding RNAs in multiple myeloma. Eur J Haematol 2019;103:3-9. [PMID: 30985973 DOI: 10.1111/ejh.13237] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
10 Yang Z, Zhao S, Zhou X, Zhao H, Jiang X. PCAT-1: A pivotal oncogenic long non-coding RNA in human cancers. Biomed Pharmacother 2019;110:493-9. [PMID: 30530229 DOI: 10.1016/j.biopha.2018.12.014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
11 Zhang F, Chen X, Xi K, Qiu Z, Wang Y, Gui Y, Hou Y, Chen K, Zhang X. Long noncoding RNA HOXD-AS1 in various cancers: a meta-analysis and TCGA data review. Onco Targets Ther 2018;11:7827-40. [PMID: 30464530 DOI: 10.2147/OTT.S184303] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
12 Yu L, Qu H, Yu Y, Li W, Zhao Y, Qiu G. LncRNA-PCAT1 targeting miR-145-5p promotes TLR4-associated osteogenic differentiation of adipose-derived stem cells. J Cell Mol Med 2018;22:6134-47. [PMID: 30338912 DOI: 10.1111/jcmm.13892] [Cited by in Crossref: 41] [Cited by in F6Publishing: 46] [Article Influence: 10.3] [Reference Citation Analysis]
13 Lee KH, Park HM, Son KH, Shin TJ, Cho JY. Transcriptome Signatures of Canine Mammary Gland Tumors and Its Comparison to Human Breast Cancers. Cancers (Basel) 2018;10:E317. [PMID: 30205506 DOI: 10.3390/cancers10090317] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
14 Chen C, Feng Y, Wang X. LncRNA ZEB1-AS1 expression in cancer prognosis: Review and meta-analysis. Clinica Chimica Acta 2018;484:265-71. [DOI: 10.1016/j.cca.2018.06.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]